Log In
BCIQ
Print this Print this
 

Dry Powder iCALM, PUR118

  Manage Alerts
Collapse Summary General Information
Company Pulmatrix Inc.
DescriptionDry powder formulation of an inhaled cationic airway lining modulator (iCALM)
Molecular Target
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$1.4M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/16/2015

Undisclosed

Undisclosed

Undisclosed

09/24/2012

$1.4M

Undisclosed

Undisclosed

Get a free BioCentury trial today